| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 20.03▼ | 20.04▼ | 19.97▲ | 19.50▲ | 22.69▼ |
| MA10 | 20.03▼ | 19.94▲ | 19.81▲ | 20.08▼ | 23.26▼ |
| MA20 | 20.03▼ | 19.75▲ | 19.46▲ | 23.98▼ | 23.40▼ |
| MA50 | 19.99▲ | 19.37▲ | 19.68▲ | 24.23▼ | 23.92▼ |
| MA100 | 19.83▲ | 19.72▲ | 22.91▼ | 23.30▼ | 34.53▼ |
| MA200 | 19.49▲ | 23.30▼ | 24.21▼ | 22.62▼ | 45.03▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.023▲ | 0.127▲ | -0.639▼ | -0.374▼ |
| RSI | 51.189▲ | 63.811▲ | 59.982▲ | 37.214▼ | 43.005▼ |
| STOCH | 34.259 | 77.851 | 79.072 | 11.621▼ | 36.352 |
| WILL %R | -72.222 | -20.301▲ | -11.250▲ | -89.211▼ | -89.211▼ |
| CCI | 5.761 | 68.222 | 98.296 | -52.070 | -147.320▼ |
|
Wednesday, November 12, 2025 09:37 AM
Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.
|
|
Wednesday, November 12, 2025 04:22 AM
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with SYFOVRE® (pegcetacoplan ...
|
|
Thursday, November 06, 2025 08:07 AM
Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/11/25 | 19.42 | 20.16 | 19.42 | 20.02 | 1,811,500 |
| 11/11/25 | 19.15 | 20.005 | 18.93 | 19.51 | 2,141,061 |
| 10/11/25 | 19.34 | 19.56 | 18.95 | 19.00 | 2,108,478 |
| 07/11/25 | 19.53 | 19.69 | 18.755 | 19.26 | 5,097,306 |
| 06/11/25 | 19.80 | 20.12 | 19.53 | 19.71 | 2,160,966 |
| 05/11/25 | 20.50 | 20.64 | 19.93 | 19.95 | 3,084,447 |
| 04/11/25 | 20.49 | 20.65 | 19.44 | 20.47 | 3,904,613 |
| 03/11/25 | 21.245 | 21.41 | 20.12 | 20.69 | 3,734,011 |
| 31/10/25 | 21.00 | 21.7999 | 19.25 | 21.47 | 6,490,189 |
| 30/10/25 | 24.85 | 25.35 | 20.66 | 20.73 | 9,883,448 |
|
|
||||
|
|
||||
|
|